An Open Label, Three-period, Single Sequence Study to Evaluate the Pharmacokinetic Drug-drug Interaction Between LCZ696 and Sildenafil in Subjects With Mild to Moderate Hypertension
Phase of Trial: Phase II
Latest Information Update: 10 Oct 2015
At a glance
- Drugs Sacubitril/valsartan (Primary) ; Sildenafil (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Novartis
- 01 Jan 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Aug 2012 Actual initiation date (8 Aug 2012) added as reported by European Clinical Trials Database record.
- 11 Aug 2012 New source identified and integrated (European Clinical Trials Database record; EudraCT2012-001632-64).